Ultrasound-Triggered Site-Specific Chemistry Redefines Precision Oncology
Bioconjugate Chemistry · 2026
DOI: 10.1021/acs.bioconjchem.6c00403 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioconjugate Chemistry, 2026. Verfasst von Xinxin Xie und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Ultrasound Targeted Drug Delivery and Frontier Imaging Technology, Department of Ultrasound, Peking University Third Hospit…. Hauptthemen laut MEDLINE: Precision Medicine, Neoplasms, Ultrasonic Waves. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Peking University Medicine Sailing Program for Young Scholars' Scientific and Technological Innovation, National Natural Science Foundation of China, Peking University Third Hospital.
Abstract (Originalsprache)
Ultrasound-triggered site-specific molecular chemistry has emerged as a transformative strategy for cancer therapy, yet precise spatiotemporal control of their activity remains a critical bottleneck. Endogenous stimulus-responsive strategies are hampered by tumor heterogeneity, while exogenous physical triggers provide superior controllability. This article proposes that ultrasound-triggered site-specific chemistry, termed “acoustic programming”, offers a transformative solution. By integrating focused ultrasound deep-tissue penetration with molecular-level chemical control, acoustically programmable bioconjugates achieve deep-tissue, on-demand therapeutic activation. We survey recent advances in sono-labile linkers, ultrasound-triggered charge reversal, and sono-chemically activated prodrugs, and critically evaluate emerging proof-of-concept and in vivo validated applications in ultrasound-caged PROTACs, immunomodulators, and antibody-drug conjugates. This paradigm shift from “ultrasound-responsive materials” to “ultrasound-responsive molecules” positions acoustic programming as a core platform technology for next-generation precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Key Laboratory of Ultrasound Targeted Drug Delivery and Frontier Imaging Technology, Department of Ultrasound, Peking University Third Hospital, Beijing100191, P. R. China.
- State Key Laboratory of Vascular Homeostasis and Remodeling, Beijing Key Laboratory of Interdisciplinary Research in Gastrointestinal Oncology (BLGO), Peking University Third Hospital, Beijing100191, P. R. China.
- Nanotechnology R&D Laboratory, Karamanoglu Mehmetbey University, 70100Karaman, Turkey.
- Department of Metallurgical and Materials Engineering, Karamanoglu Mehmetbey University, 70100Karaman, Turkey.
- Department of Bioengineering, Karamanoglu Mehmetbey University, 70100Karaman, Turkey.
ORCID-Profile: Savas Sonmezoglu, Ozlem Ates Sonmezoglu, Xiaolong Liang
Förderung
- Peking University Medicine Sailing Program for Young Scholars' Scientific and Technological Innovation
- National Natural Science Foundation of China
- Peking University Third Hospital
- Beijing Natural Science Foundation
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Xie, X., Xu, S., Wang, H., Tong, Y., Sonmezoglu, S., Sonmezoglu, O. A., & Liang, X. (2026). Ultrasound-Triggered Site-Specific Chemistry Redefines Precision Oncology. Bioconjugate Chemistry. https://doi.org/10.1021/acs.bioconjchem.6c00403
Vancouver
Xie X, Xu S, Wang H, Tong Y, Sonmezoglu S, Sonmezoglu OA, et al. Ultrasound-Triggered Site-Specific Chemistry Redefines Precision Oncology. Bioconjugate Chemistry. 2026. doi:10.1021/acs.bioconjchem.6c00403
BibTeX
@article{Xie2026,
author = {Xie, Xinxin and Xu, Shuyu and Wang, Haonan and Tong, Yuxuan and Sonmezoglu, Savas and Sonmezoglu, Ozlem Ates and Liang, Xiaolong},
title = {Ultrasound-Triggered Site-Specific Chemistry Redefines Precision Oncology},
journal = {Bioconjugate Chemistry},
year = {2026},
doi = {10.1021/acs.bioconjchem.6c00403}
}
EUVIMED